yingweiwo

CD19

CD19

CD19 related products

Structure Cat No. Product Name CAS No. Product Description
Anti-Mouse CD19 Antibody (1D3) V78042 Anti-Mouse CD19 Antibody (1D3) Anti-Mouse CD19 Antibody (1D3) is an anti-mouse CD19 IgG2a antibody inhibitor.
CD19 CAR circRNA V78686 CD19 CAR circRNA CD19 CAR circRNA can express CD19 car protein and can be used for chimeric antigen receptor T cell immunotherapy (CAR-CD19).
CD19 car circRNA-LNP V78687 CD19 car circRNA-LNP CD19 car circRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car circRNA, which is suitable for detection of RNA delivery, translation efficiency, cell viability, etc.
CD19 car mRNA-LNP V78689 CD19 car mRNA-LNP CD19 car mRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car mRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc.
CD19 CARmRNA V78688 CD19 CARmRNA CD19 CAR mRNA can express CD19 car protein and can be used for chimeric antigen receptor T cell immunotherapy (CAR-CD19).
Duvortuxizumab (MGD 011) V74757 Duvortuxizumab (MGD 011) 1831098-91-9 Duvortuxizumab (MGD 011) is a chimeric humanized IG antibody targeting CD19 and CD3E.
Englumafusp alfa (CD19-4-1BBL; RO7227166; RG6076) V79307 Englumafusp alfa (CD19-4-1BBL; RO7227166; RG6076) Englumafusp alfa (CD19-4-1BBL; RO7227166) is a fusion construct consisting of a CD19-specific antibody domain fused to the trimerizing ectodomain of human 41BBL.
Loncastuximab (RB-4v1.2) V51117 Loncastuximab (RB-4v1.2) 1875032-68-0 Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody (mAb).
MDX-1342 V74758 MDX-1342 1646327-65-2 MDX-1342 is a fully human monoclonal antibody (mAb) (HuMAb) targeting the CD19 membrane receptor.
Obexelimab (XmAb5871) V74756 Obexelimab (XmAb5871) 1690307-05-1 Obexelimab (XmAb5871) is a humanized anti-CD19 antibody Fc-engineered to increase affinity for FcγRIIb.
Taplitumomab paptox V74760 Taplitumomab paptox 235428-87-2 Taplitumomab paptox is an anti-CD19 monoclonal antibody (mAb).
Tisagenlecleucel (CTL019) V74759 Tisagenlecleucel (CTL019) 1823078-37-0 Tisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T cell therapy.
Contact Us